Planned phase I trial to investigate the tolerability of APF 580 for the treatment of pain.

Trial Profile

Planned phase I trial to investigate the tolerability of APF 580 for the treatment of pain.

Planning
Phase of Trial: Phase I

Latest Information Update: 15 May 2008

At a glance

  • Drugs APF 580 (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 15 May 2008 A.P. Pharma expects to initiate the trial in the 2nd quarter of 2008.
    • 03 Dec 2007 New trial record.
    • 14 Nov 2007 Plan to initiate phase I trial in first half of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top